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Abstract 
The average diet may provide some 8-10 g/day of unsaturated fatty acids with a trans double bond. Previous 
studies howed that dietary trans fatty acids may simultaneously raise low-density lipoprotein (LDL) cholesterol and 
reduce high-density lipoprotein (HDL) cholesterol. Human plasma contains a protein (CETP) which transfers 
cholesterylesters f om HDL to lipoproteins of lower density. We hypothesized that CETP could play a role in the 
effect of trans fatty acids on lipoproteins and measured the activity levels of CETP in serum samples from a 9-week 
study in which 55 volunteers were fed three controlled iets with different fatty acid profiles. Mean activity was 114 
(% of reference serum) after consumption of a high trans fatty acid diet, as opposed to 96 after linoleic acid and 97 
after stearic acid (P < 0.02). We conclude that the increased activity of CETP may contribute to the rise in LDL 
cholesterol and the fall in HDL cholesterol seen on diets with high contents of trans fatty acids. 
Keywords: Atherosclerosis; Coronary heart disease; Dietary trans fatty acids; Cholesterylester transfer protein 
(CETP); High-density lipoproteins (HDL); Lecithin:cholesterol acyltransferase (LCAT); Low-density lipoproteins 
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1. Introduction 
Commercial hardening of vegetable oils leads to 
the formation of unsaturated fatty acids with 
Abbreviations: Apo, apolipoprotein; CETP, cholesterylester 
transfer protein; HDL, high-density lipoproteins; LCAT, 
lecithin:cholesterol acyl-transferase; LDL, low-density lipo- 
proteins; VLDL, very-low-density l poproteins. 
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4360615. 
double bonds in the trans instead of the natural 
cis configuration. The same process takes place in 
the rumen of cows and sheep and trans fatty acids 
produced here end up in the milk and meat of 
these species. As a result the average daily US diet 
contains 8-10 grams of trans unsaturated fatty 
acids [1]. 
Dietary trans fatty acids may simultaneously 
raise low-density lipoprotein (LDL) cholesterol 
and reduce high-density lipoprotein (HDL) 
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cholesterol levels [2-4], or at least elevate LDL 
cholesterol/HDL cholesterol [5,6]. These changes 
represent a more atherogenic lipoprotein profile, 
which could explain the association of trans fatty 
acid intake and coronary heart disease reported in 
women [7]. 
Animal species that lack cholesterylester trans- 
fer protein (CETP) activity in plasma (e.g. the rat) 
have low LDL and relatively high plasma HDL 
cholesterol concentrations and tend to be resistant 
to atherosclerosis. Susceptibility to atherogenic 
diets is high in species with high plasma CETP 
activity like rabbits and man [8]. CETP catalyzes 
the transfer of plasma cholesterylesters, synthe- 
sized by lecithin:cholesterol acyltransferase 
(LCAT), from HDL to the apolipoprotein (apo) 
B-containing lipoproteins LDL and very low-den- 
sity lipoproteins (VLDL) [9]. The HDL choles- 
terol concentration is elevated in plasma of 
individuals with familial CETP deficiency, and 
some of these families appear to experience 
longevity [I0]. Intravenous injection of purified 
human CETP into rats results in a decrease in 
HDL cholesterol and in a doubling of plasma apo 
B levels [11]. Also, the expression of human CETP 
in transgenic mice leads to a substantial decrease 
in HDL cholesterol, especially when the mice also 
express the human apo A-I gene [12]. Information 
on the regulation of plasma CETP activity is 
incomplete. The present knowledge on this subject 
has been reviewed recently [13]. 
We hypothesized that plasma CETP activity 
could play a role in the induction of low HDL 
and high LDL cholesterol levels by dietary trans 
fatty acids in man. We therefore measured the 
serum activity levels of CETP (using excess exoge- 
nous substrate assays) in sera from a diet study 
involving the comparison of linoleic acid, stearic 
acid and trans fatty acids under carefully con- 
trolled conditions [3]. 
2. Methods 
[2,3]. The present data were obtained using spare 
sera stored at -80°C from the study described 
[3]. For details of the diet study (subjects, proto- 
col, diet composition and effects on serum lipids 
and lipoproteins), refer to the original reference 
[3]. In short, the trial consisted of three consecu- 
tive 3-week periods, during which each participant 
consumed each of three diets, rich in either trans 
fatty acid, stearic acid or linoleic acid. Each of the 
six possible diet sequence groups had a nearly 
equal number of male and female subjects, and of 
women using and not using oral contraceptives. 
In this way, bias due to order in which the diets 
are consumed, drift of variables over time, or to 
effects of hormonal cycle was eliminated. 
The data were analyzed applying a within-sub- 
jects model of the Statistical Analysis System 
(SAS Institute). When the analysis of variance 
indicated a significant effect of diet (P < 0.05), 
the Tukey method was used for pairwise compari- 
sons of the diets and for calculation of 95% 
confidence intervals. Only P-values < 0.02 were 
considered significant after this adjustment for 
multiple comparisons. 
Fifty-six healthy, normolipidemic volunteers 
completed the original trial [3], but for the present 
analysis one serum sample was missing of one 
man on the high-elaidic acid diet. All present 
analyses are therefore based on 30 women and 25 
men, in whom CETP and LCAT were determined 
after 17 days on each of the three diets. 
2.2 Diets 
The composition of the three diets was similar 
[3], except for about 8% of daily energy, which 
was supplied by either linoleic, stearic or trans 
fatty acids. The diets consisted of conventional 
solid foods and menus were changed aily during 
each 3-week cycle. All foodstuffs were supplied 
individually according to each person's energy 
requirement. Body weights were essentially con- 
stant during the 9 weeks of the study. 
2. I. Design and statistical analysis 
The hypothesis that CETP was involved in the 
lowering of HDL and increase in LDL seen after 
the consumption of dietary trans fatty acids arose 
after the lipoprotein data had been published 
2.3. LCAT and CETP assays 
CETP activity was assayed in the supernatant 
fraction of each serum after removal of endoge- 
nous VLDL + LDL by phosphotungstate/Mg 2+ 
precipitation [14]. The assay detects the transfer/ 
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exchange of cholesterylesters between excess ex- 
ogenous [~4C]cholesterylester-labelled LDL and 
excess exogenous unlabelled normal HDL, while 
LCAT is inhibited with 2 mmol/1 of 2-nitro-ben- 
zoic acid [15]. Exogenous HDL-cholesterylesters 
(200 nmoles) are added to the assay system 
providing a 10=15-fold excess over the endoge- 
nous HDL-cholesterylesters present. It was shown 
before that the assay measures identical activities 
with added HDL-cholesterylesters in the range 
of 150-300 nmoles. It is therefore highly un- 
likely that small changes in the composition of 
endogenous HDL (e.g. the changes in the 
cholesterylester/triglyceride atio as shown in the 
present paper) will affect the results. Incubations 
were for 16 h at 37°C. The reaction was stopped 
by cooling the tubes to 4°C and LDL was precip- 
itated from the incubation mixture with Mg-phos- 
photungstate [16] and the radioactivity was 
measured in the HDL-containing supernatant. 
CETP activity was calculated as the bidirectional 
transfer of cholesterylesters between radiolabelled 
LDL and HDL [15]. 
Serum LCAT activity levels were determined 
using excess exogenous ubstrate containing [3H]- 
cholesterol [17]. Samples were incubated for 6 h at 
37°C in a total volume of 0.145 ml before the 
reaction was stopped by addition of 0.30 ml cold 
methanol and the lipids were extracted twice with 
0.4 ml hexane. Free and ester±fled cholesterol were 
separated using disposable silica columns. [3H]- 
cholesterylesters were eluted with 3.0 ml hex- 
ane:diethylether (6:1, v/v). 
LCAT and CETP activity assays were per- 
formed in duplicate. The measured activities were 
linear with the amount of serum used. The within- 
assay coefficients of variation are 4.5% and 2.7%, 
respectively. The measured activities reflect the 
activity of LCAT or CETP as such, and are 
independent of the endogenous lipoproteins 
present in each serum. The activities were ex- 
pressed in arbitrary units, relative to the activities 
in a human pool serum that was included in each 
run (% reference serum). LCAT and CETP activi- 
ties are stable during storage of serum at - 80°C. 
The pooled human serum, used as a reference 
serum included in each assay run, was prepared in 
1988 and kept at this temperature. A second 
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reference serum (pooled human serum prepared in 
1994) had identical CETP and LCAT activity 
levels if compared in the same assay run, indicat- 
ing the stability of the activities over a 5-6 year 
period in samples stored at -80°C.  Of course 
small intrinsic differences between the activities in 
the 1988 and 1994 reference sera may exist and 
therefore minor changes during storage cannot be 
excluded completely. The absolute activities in the 
1988 pool serum were 181.9 and 39.2 nmoles/ml/h 
for CETP and LCAT, respectively. 
3. Results 
CETP and LCAT activities are shown in Table 
1. LCAT activities were not significantly different 
between the diet groups and the same activity 
levels were measured in males and females. In 
contrast, CETP activity was specifically elevated 
on the t rans -d ie t  compared with the other two 
diets. The CETP activities measured after the 
stearate-diet and the linoleate-diet were identical, 
despite the higher VLDL + LDL cholesterol after 
the stearate-diet [3]. The t rans -d ie t  was accompa- 
nied by an 18% increase in CETP activity if all 
subjects were analysed together. CETP activity 
levels in females and males were not significantly 
different on any diet. The increase in CETP act±v- 
Table 1 
Mean activity of LCAT and CETP on the three study diets a
Linoleate Stearate Elaidate 
diet diet diet 
LCAT 
Men 84.1 ±_ 19.0 . 90.8 + 18.1 84.3 ± 18.9 
Women 86.2 ± 16.2 87.4 ± 18.8 85.2 + 15.2 
All 85.2 + 17.4 88.9 + 18.4 84.8 ± 16.8 
CETP 
Men 97.5 ± 19.9 98.1 ± 20.6 117.7 ± 24.9 b'c 
Women 95.2 ± 21.4 96.6 ± 19.6 111.5 ± 21.5 bx 
All 96.2 ± 20.5 97.3 ± 19.9 114.3 ± 23.1 b'~ 
a The 25 men and 30 women consumed each diet for three 
weeks, in random order. Activities were determined in fasting 
serum samples obtained after 17 days on each diet, expressed 
as % of the activity in a reference s rum + S.D. 
b Significantly different from high-linoleate diet; P < 0.02. 
° Significantly different from high-stearate di t; P < 0.02. 
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Fig. 1. Individual changes in CETP activity on diets high in trans fatty acids or stearic acid, relative to a diet high in linoleic acid. 
Bars indicate the CETP activity of each individual subject when on a particular diet minus his or her activity when on the linoleic 
acid diet. 
ity after the trans-diet was seen in 52 out of 55 
individuals; one individual showed no effect and 
two showed a decrease in activity. Fig. 1 illus- 
trates these individual changes on the trans-diet 
or stearate-diet, relative to the linoleate-diet. 
The increased CETP activity on the trans-diet 
coincided with a low cholesterylesters/triglycerides 
in HDL. The average molar ratio (_+ S.D.) was 
6.15 _+ 1.83 on the trans-diet vs. 6.97 _+ 2.19 on 
the linoleate-diet and 6.71 _+ 2.25 on the stearate- 
diet (P < 0.02). 
4. Discussion 
We observed a specific elevation in serum 
CETP activity in subjects fed diets enriched in 
trans fatty acids: by 21% in males and by 17% in 
females. LCAT activity levels were not signifi- 
cantly different on the three diets. Compared with 
the linoleate-diet, only the trans-diet increased 
CETP activity, even though both the stearate-diet 
and the trans-diet resulted in an increase in LDL 
cholesterol, and in the VLDL + LDL cholesterol/ 
HDL cholesterol ratio and total serum choles- 
terol/HDL cholesterol ratio [3]. Thus the effects 
on VLDL + LDL cholesterol levels and on CETP 
activity are not obligatory coupled. This is not 
surprising because, in addition to possible effects 
of CETP, VLDL and LDL synthesis and degrada- 
tion are major contributors to plasma 
VLDL + LDL cholesterol levels. At the individual 
level, changes in CETP activity between diets were 
only weakly associated with changes in lipo- 
protein composition and concentration. The 
strongest correlation observed (r = 0.35, 
P=0.008) was between the changes in CETP 
activity and apolipoprotein B concentration on 
the trans-diet versus the stearate-diet. However, 
random noise in both the lipoprotein and CETP 
measurements will attenuate such individual asso- 
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ciations and very large groups of subjects are 
required to allow the signal to rise above the 
noise. 
It was rel~orted that high concentrations of 
elaidic acid, added in vitro, may increase the 
transfer of cholesterylesters f om HDL to LDL 
[18]. Therefore, trans fatty acids could act by 
increasing the serum levels of CETP, as suggested 
by our data, or by increasing the efficiency of the 
transfer process, as found in the in vitro experi- 
ments. Recently, Abbey and Nestel [19] reported 
increased CETP activity after substitution of 
trans-elaidic acid for cis-oleic acid in the diet. A 
significant increase was only detected using a 
CETP activity assay employing endogenous lipo- 
proteins, but absent if CETP activity was assayed 
in lipoprotein-deficient plasma. The CETP activ- 
ity assay used in the present experiments i inde- 
pendent of endogenous lipoproteins [15] and 
correlates very well with CETP mass [20]. So 
dietary trans fatty acids may increase the transfer 
of cholesterylesters by increasing CETP mass as 
well as by changing the structure of plasma lipo- 
proteins, resulting in better substrates for CETP 
action. Alternatively, trans fatty acids could de- 
crease the activity of putative CETP inhibitors 
[211. 
Analysis of the lipid composition in HDL re- 
vealed the lowest cholesterylester/triglyceride ratio
on the diet high in trans fatty acids. This may 
indicate that the high plasma CETP activity 
found on this diet indeed affects the lipid transfer 
reactions between lipoproteins (exchange of 
cholesterylesters in HDL for triglycerides in 
VLDL) occurring in vivo. It cannot be excluded 
however that other actions of dietary trans fatty 
acids affecting HDL (e.g. effects on HDL2/HDL 3 
via LCAT action, lipoprotein lipase and hepatic 
lipase) also explain the changes in chemical com- 
position of HDL. It was shown before that the 
fatty acid profile of serum cholesterylesters was 
influenced significantly by the various diets confir- 
ming the subjects' adherence to the diets [3]. The 
trans-diet resulted in a several fold increase in 
cholesterylesters with transC18: l  fatty acid, but 
even on this diet only about 1% of serum choles- 
terol was esterified with transC18: l  fatty acid 
(compared with 0-0.3% on the stearate-diet). This 
was the only significant difference in 
cholesterylester fatty acid profile between these 
two diets [3]. It is highly unlikely that these small 
changes in cholesterylester fatty acid profile con- 
tribute to the observed ifferences in CETP activ- 
ity, using an assay method which is not influenced 
by the concentration of endogenous lipoproteins. 
Recent data indicate an effect of exercise on 
plasma CETP activity [22,23], but our study sub- 
jects (aged 19-49 years) did not change their 
excercise habits during the course of the experi- 
ment [3]. As in a previous study [16], we were 
unable to detect significant differences in CETP 
activity between males and females. This is in line 
with published data on CETP mass in elderly, 
sedentary subjects [22], as well as CETP activity 
(measured with exogenous substrates) in 
marathon runners aged 25-51 years [23]. 
Diminished levels of plasma CETP activity are 
often associated with a low-risk lipoprotein profile 
[8-11], while increased CETP levels are found in 
patients with vai-ious forms of hyperlipidemia 
[24]. Also, intravenous injection of CETP into rats 
[11], or introduction of CETP into mice by trans- 
genesis [12] results in a rise in LDL and a fall in 
HDL cholesterol. These changes are similar as 
seen in humans consuming high trans fatty acid 
diets [2-4]. Experiments with mice [25] and mon- 
keys [26] fed atherogenic diets, revealed close cor- 
relations between atherosclerosis development, 
LDL cholesterol concentrations and plasma 
CETP levels. Our present data support he notion 
that the increased CETP activity induced by di- 
etary trans fatty acids may contribute to unfavor- 
able lipoprotein profiles and atherogenesis. 
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